Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, ...

KBC Group NV increased its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 78.2% during the 4th ...

In recent developments on Wall Street, Rhythm Pharmaceuticals (NASDAQ:RYTM) received an Equal-Weight recommendation from Morgan Stanley on Tuesday. The investment bank has set a ...

The fireside chat will be webcasted and available under “Events & Presentations” in the Investor Relations section of the Company’s website at www.rhythmtx.com. A replay of the webcast will be ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oric Pharmaceuticals (ORIC – Research Report) ...

Rhythm Pharmaceuticals, Inc. BOSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives ...

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported Q4 EPS of ($0.75), $0.06 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $8.8 million versus the ...

BOSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.